US6194530B1 - Polymers with anti-microbial properties - Google Patents

Polymers with anti-microbial properties Download PDF

Info

Publication number
US6194530B1
US6194530B1 US09/308,130 US30813099A US6194530B1 US 6194530 B1 US6194530 B1 US 6194530B1 US 30813099 A US30813099 A US 30813099A US 6194530 B1 US6194530 B1 US 6194530B1
Authority
US
United States
Prior art keywords
monomer
monomers
meth
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/308,130
Inventor
Wolfgang Klesse
Martina Pfirmann
Frank Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Roehm GmbH Darmstadt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19646965A external-priority patent/DE19646965C2/en
Application filed by Roehm GmbH Darmstadt filed Critical Roehm GmbH Darmstadt
Assigned to ROEHM GMBH reassignment ROEHM GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HILL, HELLA AS HEIRESS FOR FRANK HILL (DECEASED), KLESSE, WOLFGANG, PFIRMANN, MARTINA
Application granted granted Critical
Publication of US6194530B1 publication Critical patent/US6194530B1/en
Assigned to EVONIK ROHM GMBH reassignment EVONIK ROHM GMBH CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ROHM GMBH
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00Copolymers in which the nature of only the monomers in minority is defined

Definitions

  • the invention relates to polymers with antimicrobial properties.
  • the polymers according to the invention comprise vinyl-type polymerizable monomers which are known themselves as well as monomers in which at least one long-chain alkyl residue is bonded to a quaternary ammonium group, which in turn is bonded with a vinyl function via a hydrophilic spacer and if applicable a linking unit.
  • European Patent Application 0641805 A1 describes polymers with antimicrobial (biophobic) properties.
  • the polymers comprise ethylene-type unsaturated monomers containing some antimicrobial phenolic agents bonded covalently via side groups.
  • the phenolic agents are bonded to repeat units having functional groups that can react with amino or hydroxyl groups.
  • Examples of reactive residues are hydroxy, hydroxyalkyl, dialkylaminoalkyl or haloalkyl groups.
  • the phenolic residues of the monomers having biocidal function are therefore bonded with the polymer matrix via relatively short, hydrophobic spacers.
  • the object of the invention is to provide copolymers which are obtained by copolymerization of monomers having antimicrobial effect and which are suitable for making coatings or shaped articles whose surfaces have biocidal or biophobic properties without releasing toxic compounds. In this way it is intended that subsequent addition of microbiologically active molecules to surfaces by analogy with polymers can be avoided. Another goal is to discover a class of active substances as an alternative to the phenolic compounds, among other purposes to prevent selection of resistant strains by variation or combination of active substances and to close gaps in activity.
  • polymers of the following structure have good antimicrobial properties.
  • the polymers comprise
  • V vinyl, (meth)acroyl, allyl or styryl
  • HSp a hydrophilic spacer of general formula
  • R 1 CH 3 , ethyl or benzyl
  • R 2 an alkyl residue with 8 to 20 C atoms
  • t 1, 2 or 3.
  • Monomers a) are preferably chosen mainly from the (meth)acrylic acid esters. Especially preferred are polymers in which monomers b) are (meth)acrylic acid esters of general formula (II)
  • n 1, 2 or 3
  • n 2 to 40
  • R 3 H or CH 3 ,
  • R 4 H or CH 3
  • monomers b) in which a combination of the quaternary ammonium group which contains at least one long-chain alkyl residue and which is bound to a hydrophilic spacer represents the active principle having antimicrobial activity in the polymers according to the invention. This was in no way foreseeable.
  • monomers, especially (meth)acrylic acid esters, which contain vinyl groups and which can undergo radical polymerization to form the antimicrobial polymers opens diverse possibilities of controlling the further polymer properties such as glass transition temperature, minimum film-forming temperature, molecular weight, etc., and so antimicrobial polymers are accessible for a multitude of applications.
  • the polymers according to the invention with antimicrobial properties can be obtained in a way known in itself by radical polymerization of the monomers in the presence of polymerization initiators and if necessary molecular weight regulators.
  • nonfunctional vinyl-type polymerizable monomers a) nonfunctional vinyl-type polymerizable monomers and b) functional vinyl-type polymerizable monomers of general formula (I).
  • functional monomers relates to monomers b) in the sense that the antimicrobial property of the polymers is attributed to their presence.
  • an antimicrobial property is understood as a germ-reducing or germ-killing action which occurs when the polymer and germs come into contact with one another in the presence of water.
  • Suitable nonfunctional vinyl-type polymerizable monomers according to a) are acrylate or methacrylate compounds, allyl compounds, styrenes, maleic acid, maleic anhydride or other vinyl compounds, such as vinyl esters, etc.
  • Monomers a) preferably comprise mainly (meth)acrylate compounds, or in other words such compounds account for at least 90% relative to the total quantity of monomers a). Of course, relatively small proportions such as up to 10% of other monomers a) can also be included.
  • alkyl (meth)acrylates with 1 to 20 C atoms in the alkyl residue, hydroxy (meth)acrylates or even (meth)acrylate compounds with acid or amide functions.
  • Examples are methyl methacrylate, methyl acrylate, ethyl acrylate, butyl acrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, cyclohexyl methacrylate, hydroxyethyl (meth)acrylate, acrylic acid, methacrylic acid, acrylamide, methacrylamide. Relatively small proportions of cross-linking compounds such as glycol dimethacrylate or allyl methacrylate can also be included.
  • Preferred monomers are alkyl (meth)acrylates.
  • Especially preferred monomers a) are methyl methacrylate and butyl acrylate.
  • V vinyl, (meth)acroyl, allyl or styryl; (meth)acryloyl is preferred
  • HSp a hydrophilic spacer of general formula
  • n 1, 2 or 3, preferably 1 or 2 and
  • R 1 CH 3 , ethyl or benzyl, preferably CH 3
  • R 2 an unbranched alkyl residue with 8 to 20, preferably 12 to 18, especially preferably 12 or 14 C atoms, where
  • t 1, 2 or 3, preferably 1 or 2
  • X ⁇ Cl ⁇ , Br ⁇ , I ⁇ or (alkyl sulfate) ⁇ (preferred alkyl sulfates are CH 3 CH 2 OSO 3 ⁇ and CH 3 OSO 3 ) ⁇ ; Cl ⁇ is preferred.
  • Preferred for monomers b) are (meth)acrylic acid esters of general formula (II)
  • n 1, 2 or 3, preferably 1 or 2
  • n 2 to 40, preferably 2 to 10,
  • n can be the same or different in the individual residues.
  • R 2 an alkyl residue with 8 to 20, preferably 12 to 18, especially preferably 12 or 14
  • R 3 H or CH 3 , preferably CH 3
  • R 4 H or CH 3 , preferably H
  • X ⁇ Cl ⁇ , Br ⁇ , I ⁇ or (alkyl sulfate) ⁇ , preferably Cl ⁇ .
  • Preferred monomers b) can have general formula (III).
  • R 2 an alkyl residue with 8 to 20, preferably 12 C atoms
  • R 3 H or CH 3 , preferably CH 3
  • X ⁇ Cl ⁇ , Br ⁇ , I ⁇ or (alkyl sulfate) ⁇ , preferably Cl ⁇ .
  • An example of a preferred monomer b) is the compound laurylamine-x-10EO dimethacrylate quat (quat A) according to formula (IV)
  • monomers b) have general formula (V)
  • R 2 an alkyl residue with 8 to 20, preferably 14 C atoms
  • R 3 H or CH 3 , preferably CH 3
  • a further preferred monomer b) is the compound 2-(2′-methacroylethoxy)ethyl-dimethyltetradecylammonium chloride (quat B) according to formula (VI)
  • Monomers a) are compounds which have long been known and are accessible by standard synthesis techniques. Monomers b) are accessible by synthesis.
  • Monomers b) are prepared starting from ethoxylated amines by transesterification or esterification with (meth)acrylic acid or (meth)acrylic acid esters followed by quatemization with an alkyl chloride or dialkyl sulfate.
  • catalysts for the transesterification and esterification there can be used, as in the prior art, acids such as sulfuric acid and para-toluenesulfonic acid, basic catalysts such as calcium hydroxide, calcium oxide, lithium hydroxide, lithium amide or the like, tin catalysts such as dibutyltin oxide and dioctyltin oxide, and metal acid esters such as tetraisobutyl titanate and similar compounds.
  • An alternative preparation route is reaction of the ethoxylated amine as well as of the hydroxyalkyl methacrylate with diisocyanates or diglycidyl ethers of diols such as bisphenol A, followed by quaternization.
  • Quaternization is performed using alkyl chlorides or dialkyl sulfates in pure form or in solvents. In some cases a reaction in the autoclave (under pressure) is advantageous.
  • (meth)acrylic acid or esters thereof for transesterification or esterification of quaternary ammonium compounds having hydroxy functions is also conceivable.
  • Antimicrobial Polymers Comprising Monomers a) and b)
  • the polymers according to the invention with antimicrobial properties can be obtained in a way known in itself by radical polymerization of the monomers in the presence of polymerization initiators and if necessary molecular weight regulators.
  • nonfunctional vinyl-type polymerizable monomers a) nonfunctional vinyl-type polymerizable monomers and b) functional vinyl-type polymerizable monomers of general formula (I).
  • functional monomers relates to monomers b) in the sense that the antimicrobial property of the polymers is attributed to their presence.
  • a suitable test to check whether the antimicrobial effect is due to the polymer itself or to diffusing substances such as residual monomers contained in the polymer is one in which polymer patches are placed on a nutrient-medium slide inoculated with bacteria. If diffusing antimicrobial substances are present, they can be manifested by the development of a suppression halo, or in other words a clear zone around the polymer patch, in which bacterial growth is inhibited.
  • Other appropriate test techniques are published in, for example, European Patent Application A 641805.
  • Monomers a) can be present in proportions of 40 to 99 wt %, preferably 70 to 99, especially preferably 80 to 99, especially 85 to 95 wt %.
  • Monomers b) are present in proportions of 1 to 60 wt %, preferably 1 to 30 wt %, especially preferably 1 to 20 wt % and especially 5 to 15 wt %.
  • the polymer according to the invention can contain, for example, 30 to 70 wt %, preferably 50 to 60 wt % of methyl methacrylate and 70 to 30 wt %, preferably 35 to 45 wt % of butyl acrylate as monomers a) as well as 1 to 20, preferably 5 to 15, especially 8 to 12 wt % of laurylamine-x-10EO dimethacrylate quat (quat A) or 2-(2′-methacroylethoxy)ethyldimethyltetradecylammonium chloride (q uat B) as monomer b).
  • Adhesive coatings for application as pressure-sensitive adhesives usually have glass transition temperatures well below 0° C. They are soft and extremely tacky at room temperature.
  • the polymers can be cross-linked if desired, provided this is not detrimental to the antimicrobial action.
  • the polymers according to the invention have glass transition temperatures in the range of from ⁇ 60° C. to 150° C. Preferred values are 0° C. to 60° C.
  • the glass transition temperature Tg can be found, for example, in literature sources such as Brandrup and E. H. Immergut, “Polymer Handbook”, Interscience 1996, pp. III-61 to III-63, or “Plastics Handbook”, Volume IX, R. Vieweg and F. Esser, eds., Carl-Hanser-Verlag, Kunststoff 1975, pp. 333 to 339, and T. G. Fox in “Bull. Am. Physics Soc.”, Vol. 1 (3), p. 123 (1956).
  • the form of application or processing of the polymer can be a factor in the glass transition temperature to be obtained.
  • the person skilled in the art is aware, for example, that the choice of monomers in the case of application as an aqueous dispersion must ensure that the minimum film-forming temperatures (MFT) of the dispersion, determined per DIN 53787, must not exceed the drying temperature. In general, the MFT will lie between 0 and 60° C.
  • the choice of monomers a) is therefore made in a manner known in itself.
  • the person skilled in the art knows how to combine monomers whose homopolymers have high or low glass transition temperatures (“hardening” or “softening” monomers) in order to obtain the desired material characteristics.
  • the polymer according to the invention is not water-soluble and at most is water-swellable to a limited extent.
  • polyunsaturated monomers can also be added in more or less large proportions depending on intended purpose, form of application or manufacturing process.
  • the person skilled in the art is aware of the cases in which he must limit the proportion of such monomers, which can already lead to cross-linking of the polymers during polymerization.
  • An example is solution polymerization, in which proportions smaller than 1% can already lead to cross-linking and thus to gelling of the mixture.
  • a coating comprising monomers followed by curing on the substrate surface, for example by UV irradiation., almost arbitrarily high proportions of polyunsaturated monomers can be used.
  • monomers with low water solubility there can be provided limited proportions of monomers whose water solubility at room temperature is higher than 30 g/l, especially higher than 20 g/l.
  • the proportion must be limited to less than 30% of monomers a), and preferably it should be below 10%, especially below 5%.
  • the copolymerization of minor proportions of such monomers to obtain specified characteristics is known. Examples worth mentioning here are the improvement of adhesion to certain substrates, the increase in stability of disperse systems, the improvement of pigmentability or colorability, or the increase in resistance to chemicals by subsequent cross-linking of the polymers.
  • the person skilled in the art usually can anticipate such problems or is capable of establishing suitable polymerization conditions by preliminary experiments. For example, it may be advisable, in the case of emulsion polymerization, to do without the anionic surfactants that are normally used, in order to avoid incompatibilities with monomers b), and instead to manage with nonionic or cationic surfactants or to work entirely without surfactants.
  • copolymerizable surfactants or general stabilizing units such as alkoxyethylpolyethylene glycol (meth)acrylates is also possible.
  • molecular weight regulators such as mercaptans, by the initiator or monomer concentrations or by the polymerization temperature.
  • the copolymerization behavior is characterized by copolymerization parameters of monomer pairs (see Encyclopedia of Polymer Science and Engineering, Vol. 13, pp. 708 ff., John Wiley & Sons, 1988).
  • Preferred combinations of monomers a) and b), however, are those for which uniform copolymerization can be expected or which make it unlikely that a considerable part of the monomers will not be incorporated into the copolymer.
  • the copolymerization behavior of the most important monomers a) is known (see J. Brandrup, E. H. Immergut, Polymer Handbook, Third Ed., John Wiley & Sons, 1989).
  • the copolymerization parameters of monomers b) have not been determined by the inventors. It can be assumed, however, that the nature of the double bond substantially determines the copolymerization behavior, and so monomers b) containing a methacryloyl group have copolymerization behavior similar to that of the known methacrylates.
  • Monomers b) with a methacryloyl or acryloyl group are therefore particularly suitable for combination with methacrylates and acrylates of group a) as well as with styrene.
  • Monomers with vinyl double bonds such as vinyl chloride do not exhibit a strong tendency toward copolymerization with methacrylates or acrylates. If such monomers are to be copolymerized with monomers b), it is advantageous, on the basis of knowledge of the copolymerization parameters, for a vinyl ester group, for example, to be chosen as unsaturated group V. Similarly, a person skilled in the art can select further combinations of monomers a) and b) from which advantageous copolymerization behavior can be expected.
  • the copolymers are preferably water-insoluble and at the most have limited swellability in water. They are suitable for the synthesis of coatings and shaped articles in which microbial growth is undesirable and must be avoided. Included herein are coats such as paints for ships, paints for exterior walls, floor coverings or wood glazes, self-adhering coatings, coatings of schedules and shower curtains, finishes for textiles such as woven or nonwoven fabrics, for example for hygiene applications or for filters. Examples of shaped articles would include door handles, railings, toilet or kitchen surfaces, materials for water-conveying parts such as pipes, seals, valves, diaphragms. Textile fibers or yarns can also be made from copolymers having structures according to the invention.
  • the antimicrobial surface inhibits the growth of microorganisms in the medium adjoining the surface, so that preservative packaging of easily spoiled aqueous goods is also possible without the need for addition of toxic or unsafe substances or of release thereof from the surface.
  • Residual monomer content 296 ppm methyl methacrylate (MMA), 96 ppm butyl acrylate
  • the emulsion was cast on a glass plate bordered with silicone and was dried overnight at 50° C. to obtain a clear, transparent film. Glass transition temperature: 36° C.
  • Example 3 is repeated, with the difference that a mixture of 22.0 g of MMA, 18.0 g of butyl acrylate, 0.16 g of AIBN and 0.12 g of ethylhexyl thioglycolate is used.
  • the polymer films from Example 3 and 5 were stored for 24 hours in water, during which period the water was replaced after 8 hours. The films were then dried in air.
  • the bactericidal action of these polymer films toward the test organisms Staphylococcus aureus and Bacillus cereus was tested as follows: Each test organism was inoculated with 5 ml of standard I bouillon in an Erlenmeyer flask and incubated as a standard culture for 16 hours at 370° C. The mixture was then diluted by a factor of 1:10000. Strips (5 cm ⁇ 1 cm) of the polymer films to be examined were coated with 8 ml of this diluted mixture in sterile test tubes. Live germ counts (LGC/g) were then determined immediately and after 2, 4 and 20 hours.
  • LGC/g Live germ counts
  • test tubes were shaken during incubation. The result is summarized in the following table.
  • the polymer film of polymer 4A from Example 3 was stored in water for 24 hours, the water being replaced after 8 hours. The film was then dried in air.
  • PBS 0.05 M phosphate buffer solution, pH 7.2, 0.9% NaCl
  • the contact inhibition test described hereinabove was performed with the polymer from Example 4 (quat B as the comonomer) and four bacterial strains as well as the yeast Candida tropicalis .
  • the films obtained were stored in water for 24 hours (the water being changed several times) and tested after they had been dried in air. The lethality is reported in %. Surprisingly, selective inactivation of the yeast strain was observed, but no action was found for the bacterial strains.
  • a polyamide film strip measuring about 8 ⁇ 2 cm was immersed for half of its length into the dispersion from Example 4 and then dried for 1 hour at 70° C. The strip was water-treated for 18 hours and then dried in air at room temperature.
  • the strip coated for half of its length with the dispersion was now completely immersed in a cell suspension of Staphylococcus aureus (isolated by Gelsenmün Hygiene Institute from an infected central venous catheter). Thereafter the strip was dried briefly in air and then placed on dilute nutrient agar and cultured overnight at 370° C.

Abstract

The invention relates to polymers with antimicrobial properties, consisting of: a) 99-40 wt % non functional vinylically polymerizable monomers and b) 1-60 wt % functional vinylically polymerizable monomers of general formula (I) wherein V=vinyl, (meth)acroyl, allyl or styryl, A=a possibly available linking unit, which can be alkyl, aryl, arylalkyl or hydroxy alkyl, which can also be interrupted by hetero atoms, e.g. by hetero atoms in urethane, carbonate, ester, amide or ether groups, wherein y=0 or is 1, Hsp=a hydrophilic spacer of general formula (i) —(O—CH2—CH2)r— and/or (ii) —(O—CH2—CH(CH3))s with r=0-40, s=0-40 and r+s=2-40, also m=1.2 or 3 and R1=CH3, ethyl or benzyl, R2=an alkyl radical with 8-20 C-atoms, wherein t=1, 2 or 3 and X=Cl, Br, I or alkyl sulphate.

Description

The invention relates to polymers with antimicrobial properties. The polymers according to the invention comprise vinyl-type polymerizable monomers which are known themselves as well as monomers in which at least one long-chain alkyl residue is bonded to a quaternary ammonium group, which in turn is bonded with a vinyl function via a hydrophilic spacer and if applicable a linking unit.
PRIOR ART
European Patent Application 0641805 A1 describes polymers with antimicrobial (biophobic) properties. The polymers comprise ethylene-type unsaturated monomers containing some antimicrobial phenolic agents bonded covalently via side groups.
By analogy with polymers, the phenolic agents are bonded to repeat units having functional groups that can react with amino or hydroxyl groups. Examples of reactive residues are hydroxy, hydroxyalkyl, dialkylaminoalkyl or haloalkyl groups. The phenolic residues of the monomers having biocidal function are therefore bonded with the polymer matrix via relatively short, hydrophobic spacers.
The abstract of Japanese Patent 62-05936 (Chemical Abstracts, 107, 41977v) describes antifungal and antibacterial agents. These have a (meth)acryl residue, to which there is bonded a fluorinated aromatic group via an ethylene glycol, propylene glycol or hydroxypropylene group containing 1 to 4 units. The monomers, in the form of a polyvinyl chloride paste, are used, for example, as antimicrobial coating on paper. Use in polymers is not mentioned.
Nazarova et al. (Chemical Abstracts 122: 230183d: Khim.-Farm. Zh. (1993), 27 (2), 30-3) describe biophobic polymers of N-(2-hydroxypropyl)methacrylamide containing bound chloramphenicol.
Therein higher activity is observed in vivo when the chloramphenicol is additionally bonded to the polymer and cleaved from the polymer via a glycine-leucine-glycine spacer. The authors suspect particularly good action toward intracellular microorganisms. Obviously the ease of cleavage of the chloramphenicol from the polymer by enzymatic hydrolysis of the peptide bond is decisive for the good in vivo effect.
The incorporation of a bactericidal monomer for dental applications is described in J. Dent. Rs. 73(8), 1437-1443 (1994). An antimicrobial effect is observed without release of the active species, although it is not clear whether the effectiveness is derived from a bactericidal or biophobic (antiadhesion) property. The pyridinium compound used is bonded to the polymer skeleton via a hydrophobic spacer (long-chain alkyl residue).
OBJECT AND ACHIEVEMENT
The object of the invention is to provide copolymers which are obtained by copolymerization of monomers having antimicrobial effect and which are suitable for making coatings or shaped articles whose surfaces have biocidal or biophobic properties without releasing toxic compounds. In this way it is intended that subsequent addition of microbiologically active molecules to surfaces by analogy with polymers can be avoided. Another goal is to discover a class of active substances as an alternative to the phenolic compounds, among other purposes to prevent selection of resistant strains by variation or combination of active substances and to close gaps in activity.
It has been found that polymers of the following structure have good antimicrobial properties. The polymers comprise
a) 99 to 40 wt % of nonfunctional vinyl-type polymerizable monomers and
b) 1 to 60 wt % of functional vinyl-type polymerizable monomers of general formula (I)
[V-Ay-HSp]m-N(R1)4−(m+t)-(R2)t.X  (I)
 where
V=vinyl, (meth)acroyl, allyl or styryl,
A=a linking unit which is present if necessary, which can be alkyl, aryl, arylalkyl or hydroxyalkyl, and which can also be interrupted by heteroatoms, for example by heteroatoms in urethane, carbonate, ester, amide or ether groups, where y=0 or 1,
HSp=a hydrophilic spacer of general formula
—(O—CH2—CH2)r—  (i)
and/or
—(O—CH2—CH(CH3))s  (ii)
where r=0 to 40, s=0 to 40 and r+s=2 to 40, as well as
m=1, 2 or 3 and
R1=CH3, ethyl or benzyl
R2=an alkyl residue with 8 to 20 C atoms, where
t=1, 2 or 3.
X=Cl, Br, I or (alkyl sulfate)
Monomers a) are preferably chosen mainly from the (meth)acrylic acid esters. Especially preferred are polymers in which monomers b) are (meth)acrylic acid esters of general formula (II)
[CH2═CR3—CO—(O—CH2—CHR4)n]m-N(CH3)4−(m+t)-(R2)t.X  (II)
where
m=1, 2 or 3, n=2 to 40,
R2=an alkyl residue with 8 to 20 C atoms, where t=1, 2 or 3.
R3=H or CH3,
R4=H or CH3
X=Cl, Br, I or (alkyl sulfate)
Although the mechanism of action is not understood, the inventors assume that monomers b), in which a combination of the quaternary ammonium group which contains at least one long-chain alkyl residue and which is bound to a hydrophilic spacer represents the active principle having antimicrobial activity in the polymers according to the invention. This was in no way foreseeable. The use of monomers, especially (meth)acrylic acid esters, which contain vinyl groups and which can undergo radical polymerization to form the antimicrobial polymers opens diverse possibilities of controlling the further polymer properties such as glass transition temperature, minimum film-forming temperature, molecular weight, etc., and so antimicrobial polymers are accessible for a multitude of applications.
WORKING OF THE INVENTION
The polymers according to the invention with antimicrobial properties can be obtained in a way known in itself by radical polymerization of the monomers in the presence of polymerization initiators and if necessary molecular weight regulators.
For this purpose there are used a) nonfunctional vinyl-type polymerizable monomers and b) functional vinyl-type polymerizable monomers of general formula (I). The term functional monomers relates to monomers b) in the sense that the antimicrobial property of the polymers is attributed to their presence.
For the present purpose, an antimicrobial property is understood as a germ-reducing or germ-killing action which occurs when the polymer and germs come into contact with one another in the presence of water.
Monomers a):
Examples of suitable nonfunctional vinyl-type polymerizable monomers according to a) are acrylate or methacrylate compounds, allyl compounds, styrenes, maleic acid, maleic anhydride or other vinyl compounds, such as vinyl esters, etc.
Monomers a) preferably comprise mainly (meth)acrylate compounds, or in other words such compounds account for at least 90% relative to the total quantity of monomers a). Of course, relatively small proportions such as up to 10% of other monomers a) can also be included. Preferred are alkyl (meth)acrylates with 1 to 20 C atoms in the alkyl residue, hydroxy (meth)acrylates or even (meth)acrylate compounds with acid or amide functions. Examples are methyl methacrylate, methyl acrylate, ethyl acrylate, butyl acrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, cyclohexyl methacrylate, hydroxyethyl (meth)acrylate, acrylic acid, methacrylic acid, acrylamide, methacrylamide. Relatively small proportions of cross-linking compounds such as glycol dimethacrylate or allyl methacrylate can also be included. Preferred monomers are alkyl (meth)acrylates. Especially preferred monomers a) are methyl methacrylate and butyl acrylate.
Monomers b):
Functional vinyl-type polymerizable monomers according to b) have the general structure of formula (I)
[V-Ay-HSp]m-N(R1)4−(m+t)-(R2)t.X  (I)
where
V=vinyl, (meth)acroyl, allyl or styryl; (meth)acryloyl is preferred
A=a linking unit which is present if necessary, which can be alkyl, aryl, arylalkyl or hydroxyalkyl, and which can also be interrupted by heteroatoms, for example by heteroatoms in urethane, carbonate, ester, amide or ether groups, where y=0 or 1, although y=0 is preferred.
Examples of A are:
2-hydroxypropoxy, (2′-hydroxypropoxyphenyl)(2′-hydroxy-3-oxyphenyl)propane (from bisphenol A diglycidyl ether), 7,7,9-trimethyl-4,13-dioxo-3,14-dioxa-5,12-diazatetradecyl (from HMDI), 6-ketohexyloxy, 6-ketohexylamino, etc.
HSp=a hydrophilic spacer of general formula
—(O—CH2—CH2)r—  (i)
and/or
—(O—CH2—CH(CH3))s  (ii)
where r=0 to 40, s=0 to 40 and r+s=2 to 40
(i) or (ii) is preferred,
especially preferred with r=2 to 10 or s=2 to 10,
less preferred, but also possible, is (i) and (ii) in mixed or block sequence,
m=1, 2 or 3, preferably 1 or 2 and
R1=CH3, ethyl or benzyl, preferably CH3
(if a plurality of R1 residues are present they can be the same or different)
R2=an unbranched alkyl residue with 8 to 20, preferably 12 to 18, especially preferably 12 or 14 C atoms, where
t=1, 2 or 3, preferably 1 or 2,
X=Cl, Br, I or (alkyl sulfate) (preferred alkyl sulfates are CH3CH2OSO3 and CH3OSO3); Cl is preferred.
Preferred for monomers b) are (meth)acrylic acid esters of general formula (II)
[CH2═CR3—CO—(O—CH2—CHR4)n]m-N(CH3)4−(m+t)-(R2)t.X  (II)
where
m=1, 2 or 3, preferably 1 or 2,
n=2 to 40, preferably 2 to 10,
if m>1, n can be the same or different in the individual residues.
R2=an alkyl residue with 8 to 20, preferably 12 to 18, especially preferably 12 or 14
C atoms, where t=1, 2 or 3, preferably 1 or 2
R3=H or CH3, preferably CH3
R4=H or CH3, preferably H
X=Cl, Br, I or (alkyl sulfate), preferably Cl.
Preferred monomers b) can have general formula (III).
Figure US06194530-20010227-C00001
where
u+v=6 to 20, preferably 10
R2=an alkyl residue with 8 to 20, preferably 12 C atoms
R3=H or CH3, preferably CH3
X=Cl, Br, I or (alkyl sulfate), preferably Cl.
An example of a preferred monomer b) is the compound laurylamine-x-10EO dimethacrylate quat (quat A) according to formula (IV)
Figure US06194530-20010227-C00002
where u+v=10 (statistical distribution around the mean value u, v=5)
Preferably monomers b) have general formula (V)
CH2═CR3—CO—(O—CH2—CH2)w-N(CH3)2-R2.X  (V)
where
w=2 to 40
R2=an alkyl residue with 8 to 20, preferably 14 C atoms,
R3=H or CH3, preferably CH3
X=Cl, Br, I or (alkyl sulfate), preferably Cl.
A further preferred monomer b) is the compound 2-(2′-methacroylethoxy)ethyl-dimethyltetradecylammonium chloride (quat B) according to formula (VI)
CH2═C(CH3)—CO—(O—CH2—CH2)2-N(CH3)2-(C14H29).Cl  (VI)
Monomers a) are compounds which have long been known and are accessible by standard synthesis techniques. Monomers b) are accessible by synthesis.
General Description of the Synthesis:
Monomers b) are prepared starting from ethoxylated amines by transesterification or esterification with (meth)acrylic acid or (meth)acrylic acid esters followed by quatemization with an alkyl chloride or dialkyl sulfate. As catalysts for the transesterification and esterification there can be used, as in the prior art, acids such as sulfuric acid and para-toluenesulfonic acid, basic catalysts such as calcium hydroxide, calcium oxide, lithium hydroxide, lithium amide or the like, tin catalysts such as dibutyltin oxide and dioctyltin oxide, and metal acid esters such as tetraisobutyl titanate and similar compounds. For process stabilization there are added standard stabilizers such as hydroquinone, hydroquinone monomethyl ether, 4-methyl-2,6-di-tert-butylphenol, phenothiazine or similar compounds as well as combinations thereof. The reaction is advantageously carried out under azeotropic distillation of the resulting water of reaction and low-boiling alcohol.
An alternative preparation route is reaction of the ethoxylated amine as well as of the hydroxyalkyl methacrylate with diisocyanates or diglycidyl ethers of diols such as bisphenol A, followed by quaternization.
Quaternization is performed using alkyl chlorides or dialkyl sulfates in pure form or in solvents. In some cases a reaction in the autoclave (under pressure) is advantageous. The use of (meth)acrylic acid or esters thereof for transesterification or esterification of quaternary ammonium compounds having hydroxy functions is also conceivable.
General description of the synthesis of laurylamine-x-10EO dimethacrylate quat (quat A) and 2-(2′-methacroylethoxy)ethyldimethyltetradecylammonium chloride (quat B):
The advantageously used monomers b), especially quat A (according to formula IV) and quat B (according to formula VI) are synthesized via the methacrylate esters of the corresponding ethoxylated tertiary amines, which are obtained by transesterification with methyl methacrylate and isopropyl titanate. Quaternization is performed advantageously in the autoclave in order to reach higher temperatures. Quaternization with fatty alkyl chlorides is performed preferably in pure substance or with polar solvents, especially preferably with alcohols.
Antimicrobial Polymers Comprising Monomers a) and b)
The polymers according to the invention with antimicrobial properties can be obtained in a way known in itself by radical polymerization of the monomers in the presence of polymerization initiators and if necessary molecular weight regulators.
For this purpose there are used a) nonfunctional vinyl-type polymerizable monomers and b) functional vinyl-type polymerizable monomers of general formula (I). The term functional monomers relates to monomers b) in the sense that the antimicrobial property of the polymers is attributed to their presence.
Antimicrobial properties are understood as an inhibiting effect on the growth of microorganisms, especially bacteria or yeast fungi, or even a germ-reducing effect. Such an effect can be determined by several methods familiar to those skilled in the art. An example of a suitable method is that of the placed drop according to Nurdin, Helary and Sauvet (“Biocidal Polymers Active by Contact. II. Biological Evaluation of Polyurethane Coatings with Pendant Quaternary Ammonium Salts”, J. Appl. Pol. Sci. 50, 663-670, 1993). Therein 100 μl of a cell suspension containing approximately 10,000 bacterial cells such as Klebsiella pneumoniae is placed on a patch of the polymer to be tested and incubated for a specified time such as 3 hours. Thereafter the drop containing the cell suspension is removed and the number of colony-forming units compared with a control sample is determined. An example of a suitable test to check whether the antimicrobial effect is due to the polymer itself or to diffusing substances such as residual monomers contained in the polymer is one in which polymer patches are placed on a nutrient-medium slide inoculated with bacteria. If diffusing antimicrobial substances are present, they can be manifested by the development of a suppression halo, or in other words a clear zone around the polymer patch, in which bacterial growth is inhibited. Other appropriate test techniques are published in, for example, European Patent Application A 641805.
Monomers a) can be present in proportions of 40 to 99 wt %, preferably 70 to 99, especially preferably 80 to 99, especially 85 to 95 wt %. Monomers b) are present in proportions of 1 to 60 wt %, preferably 1 to 30 wt %, especially preferably 1 to 20 wt % and especially 5 to 15 wt %.
The polymer according to the invention can contain, for example, 30 to 70 wt %, preferably 50 to 60 wt % of methyl methacrylate and 70 to 30 wt %, preferably 35 to 45 wt % of butyl acrylate as monomers a) as well as 1 to 20, preferably 5 to 15, especially 8 to 12 wt % of laurylamine-x-10EO dimethacrylate quat (quat A) or 2-(2′-methacroylethoxy)ethyldimethyltetradecylammonium chloride (q uat B) as monomer b).
The Structure of the Polymers
Monomers a) as a rule are not critical, as long as they do not neutralize the antimicrobial effect of monomers b) on the polymer surface. The choice of monomers a) is therefore guided primarily by the intended purpose and the desired material characteristics of the polymer. If hard, mechanically resistant shaped articles are to be made, the glass transition temperature of the polymers, or the softening temperature in the case of polymers with crystalline fractions, is generally far above room temperature, or in other words between 80 and 150° C., for example. Decorative or functional coatings such as paints are frequently based on polymers with glass transition temperatures in the range of 0 to 100° C. The more flexible the coating must be, in general the lower the glass transition temperature is. Adhesive coatings for application as pressure-sensitive adhesives usually have glass transition temperatures well below 0° C. They are soft and extremely tacky at room temperature. The polymers can be cross-linked if desired, provided this is not detrimental to the antimicrobial action. The polymers according to the invention have glass transition temperatures in the range of from −60° C. to 150° C. Preferred values are 0° C. to 60° C. The glass transition temperature Tg can be found, for example, in literature sources such as Brandrup and E. H. Immergut, “Polymer Handbook”, Interscience 1996, pp. III-61 to III-63, or “Plastics Handbook”, Volume IX, R. Vieweg and F. Esser, eds., Carl-Hanser-Verlag, Munich 1975, pp. 333 to 339, and T. G. Fox in “Bull. Am. Physics Soc.”, Vol. 1 (3), p. 123 (1956).
Even the form of application or processing of the polymer can be a factor in the glass transition temperature to be obtained. The person skilled in the art is aware, for example, that the choice of monomers in the case of application as an aqueous dispersion must ensure that the minimum film-forming temperatures (MFT) of the dispersion, determined per DIN 53787, must not exceed the drying temperature. In general, the MFT will lie between 0 and 60° C.
The choice of monomers a) is therefore made in a manner known in itself. The person skilled in the art knows how to combine monomers whose homopolymers have high or low glass transition temperatures (“hardening” or “softening” monomers) in order to obtain the desired material characteristics. In the preferred embodiment, the polymer according to the invention is not water-soluble and at most is water-swellable to a limited extent.
Monomers a) therefore comprise more than 70% of monomers whose water solubility at room temperature is less than 30 g/l, especially less than 20 g/l. The proportion of such monomers is preferably more than 90%, especially preferably more than 95%. Examples are simple unsaturated monomers such as styrene, ethylene, propylene, vinyl chloride, vinylidene chloride, butadiene, vinyl and allyl esters and ethers such as vinyl acetate, esters of maleic, fumaric and itaconic acids, esters and substituted amides of methacrylic and acrylic acids as well as methacrylonitrile and acrylonitrile.
Especially preferred are the esters of methacrylic and acrylic acids, possibly in combination with styrene, substituted amides of (meth)acrylic acid and (meth)acrylonitrile. Only some representative examples will be cited from the broad selection: C1 to C20 alkyl esters of (meth)acrylic acid, especially methyl, ethyl, propyl, butyl (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, isobornyl (meth)acrylate and short-chain alkylglycol (meth)acrylates such as ethoxyethyl or butoxyethyl methacrylate or ethyltriglycol methacrylate.
Other than the singly unsaturated monomers, polyunsaturated monomers can also be added in more or less large proportions depending on intended purpose, form of application or manufacturing process. The person skilled in the art is aware of the cases in which he must limit the proportion of such monomers, which can already lead to cross-linking of the polymers during polymerization. An example is solution polymerization, in which proportions smaller than 1% can already lead to cross-linking and thus to gelling of the mixture. On the other hand, for application of a coating comprising monomers followed by curing on the substrate surface, for example by UV irradiation., almost arbitrarily high proportions of polyunsaturated monomers can be used.
Examples of such monomers are ethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, butanediol di(meth)acrylate, hexanediol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, allyl (meth)acrylate, methylenebismethacrylamide, methylenebisacrylamide, divinylbenzene and triallyl cyanurate. Of course, it would be limiting for the content of polyunsaturated monomers if the antimicrobial action were to be impaired by, for example, restricted mobility of the cross-linked polymer chains.
In addition to the monomers with low water solubility, there can be provided limited proportions of monomers whose water solubility at room temperature is higher than 30 g/l, especially higher than 20 g/l. The proportion must be limited to less than 30% of monomers a), and preferably it should be below 10%, especially below 5%. The copolymerization of minor proportions of such monomers to obtain specified characteristics is known. Examples worth mentioning here are the improvement of adhesion to certain substrates, the increase in stability of disperse systems, the improvement of pigmentability or colorability, or the increase in resistance to chemicals by subsequent cross-linking of the polymers. Examples of such monomers are polymerizable carboxylic acids such as (meth)acrylic acid, maleic acid and itaconic acid, polymerizable phosphonic or sulfonic acids such as 1-(meth)acrylamido-2-methylpropanesulfonic acid, hydroxyalkyl (meth)acrylates, glycerol monomethacrylate, glycidyl methacrylate, (meth)acrylamide, N-methylol methacrylamide and ethers thereof, maleic acid, alkoxypolyalkylene glycol (meth)acrylates, dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylamide, unsaturated ethyleneurea derivatives such as N-(2-methacryloyloxyethyl)ethyleneurea, N-vinylpyrrolidone, N-vinylimidazole and saponified vinyl acetate.
Polymerization
In principle, all appropriately used polymerization processes are suitable for synthesizing the polymers (see, for example, H. Rauch-Puntigam, Th. Voelker, Acrylic and methacrylic compounds, Springer Verlag 1967, or Encyclopedia of Polymer Science and Engineering, Vol. 13, pp. 708 ff., John Wiley & Sons, 1988). As a rule, radical polymerization using the standard radical initiators will be chosen. Examples of processes include solution, emulsion, suspension, precipitation and bulk polymerization. A substantial factor for the choice of synthesis process is the form of the application in which the polymer will be used or the nature and manner of subsequent processing/forming. Because of the amphiphilic character and the cationic charge of monomers b), however, it is possible in the individual case that solubility problems or incompatibilities will be encountered which influence the choice of polymerization process or which necessitate some adaptation of the polymerization conditions to be employed.
The person skilled in the art usually can anticipate such problems or is capable of establishing suitable polymerization conditions by preliminary experiments. For example, it may be advisable, in the case of emulsion polymerization, to do without the anionic surfactants that are normally used, in order to avoid incompatibilities with monomers b), and instead to manage with nonionic or cationic surfactants or to work entirely without surfactants. The use of copolymerizable surfactants or general stabilizing units such as alkoxyethylpolyethylene glycol (meth)acrylates is also possible.
In the case of bulk polymerization there may exist the possibility, when monomers a) are extremely hydrophobic, that monomers b) will be too poorly soluble, in which case solution or emulsion polymerization, for example, would be preferred.
It is also possible to apply and cure the monomer mixture as such on a substrate to be coated. This is a well known procedure. In this case polymerization can be initiated by thermal decomposition of initiators or by redox reactions. In most cases, however, curing is achieved by irradiation, especially UV irradiation, using photoinitiators.
The molecular weight of the polymers is not critical to the antimicrobial action. In general, it will be adjusted such that requirements of processability and material characteristics are met. In most cases, the molecular weight lies between 20,000 and 500,000. In this connection, solution polymers and polymers intended for thermoplastic processing tend to be in the lower half of this range, for example around 100,000, whereas emulsion polymers usually have higher molecular weights and tend to be in the upper half of this range. The molecular weight MW can be determined by, for example, gel permeation chromatography or a light scattering method (see, for example, H. F. Mark et al., Encyclopedia of Polymer Science and Engineering, 2nd Ed., Vol. 10, pp. 1 ff., J. Wiley, 1989). In practice, viscosity measurements are usually preferred.
Of course, lower or higher molecular weights are also possible, up to infinitely high molecular weights in cross-linked systems. The desired molecular weight can be adjusted in ways known in themselves, for example by molecular-weight regulators such as mercaptans, by the initiator or monomer concentrations or by the polymerization temperature.
In selecting monomers a) and b), it is important to consider their copolymerization behavior. The copolymerization behavior is characterized by copolymerization parameters of monomer pairs (see Encyclopedia of Polymer Science and Engineering, Vol. 13, pp. 708 ff., John Wiley & Sons, 1988).
In order to ensure uniform copolymerization of all monomers, it is advantageous to avoid combinations whose copolymerization parameters differ greatly from each other. On the other hand, the person skilled in the art is also aware of methods for forcing copolymerization within certain limits even in the case of unfavorable copolymerization parameters, for example by starting with only part of the preferably copolymerizable partners and introducing the rest to keep up with consumption in the course of polymerization. It is also conceivable that nonuniform copolymerization of the monomers may even be desired, in order to achieve special effects by the heterogeneous polymer composition.
Preferred combinations of monomers a) and b), however, are those for which uniform copolymerization can be expected or which make it unlikely that a considerable part of the monomers will not be incorporated into the copolymer. The copolymerization behavior of the most important monomers a) is known (see J. Brandrup, E. H. Immergut, Polymer Handbook, Third Ed., John Wiley & Sons, 1989). The copolymerization parameters of monomers b) have not been determined by the inventors. It can be assumed, however, that the nature of the double bond substantially determines the copolymerization behavior, and so monomers b) containing a methacryloyl group have copolymerization behavior similar to that of the known methacrylates. Monomers b) with a methacryloyl or acryloyl group are therefore particularly suitable for combination with methacrylates and acrylates of group a) as well as with styrene. Monomers with vinyl double bonds such as vinyl chloride do not exhibit a strong tendency toward copolymerization with methacrylates or acrylates. If such monomers are to be copolymerized with monomers b), it is advantageous, on the basis of knowledge of the copolymerization parameters, for a vinyl ester group, for example, to be chosen as unsaturated group V. Similarly, a person skilled in the art can select further combinations of monomers a) and b) from which advantageous copolymerization behavior can be expected.
Use and Advantageous Characteristics of the Polymers
The copolymers are preferably water-insoluble and at the most have limited swellability in water. They are suitable for the synthesis of coatings and shaped articles in which microbial growth is undesirable and must be avoided. Included herein are coats such as paints for ships, paints for exterior walls, floor coverings or wood glazes, self-adhering coatings, coatings of schedules and shower curtains, finishes for textiles such as woven or nonwoven fabrics, for example for hygiene applications or for filters. Examples of shaped articles would include door handles, railings, toilet or kitchen surfaces, materials for water-conveying parts such as pipes, seals, valves, diaphragms. Textile fibers or yarns can also be made from copolymers having structures according to the invention. In the ideal case, the antimicrobial surface inhibits the growth of microorganisms in the medium adjoining the surface, so that preservative packaging of easily spoiled aqueous goods is also possible without the need for addition of toxic or unsafe substances or of release thereof from the surface.
EXAMPLES Example 1
Synthesis of Quat A
a) Preparation of the dimethacrylate of ethoxylated laurylamine (laurylamine×10EO): 160.5 g of ethoxylated laurylamine (Marlazin L10) is dried by means of cyclohexane in the moisture separator. After distillative removal of the entraining agent, 52 mg of hydroquinone monomethyl ether, 52 mg of phenothiazine, 130 mg of N,N′-diphenyl-p-phenylenediamine and 100 g of methyl methacrylate (MMA) are added and the mixture is dried once again by azeotropic distillation. After addition of another 15 ml of MMA, 1.0 g of tetraisopropyl titanate is added at 80° C. The mixture is heated to boiling and methanol/MMA distilled off. The reaction is ended after 9 hours. The catalyst is precipitated by addition of dilute sulfuric acid and, after neutralization with aqueous sodium carbonate solution, is filtered under pressure. Excess MMA is removed in the rotary evaporator. The yield was 177.6 g; the structure was confirmed by NMR.
b) Preparation of laurylamine-x-10EO dimethacrylate quat (quat A) 85.0 g of dimethacrylate of ethoxylated laurylamine, 45.8 g of acetone, 43 mg of N,N′-diphenyl-p-phenylenediamine and 2 mg of 4-hydroxy-2,2,6,6-tetramethylpiperidinooxyl are introduced into the teflon insert of the autoclave. 4.5 g of chloromethane is introduced under pressure. Stirring is performed for 24 hours at 90° C. During this time the pressure decreases (4 to 5 bar). After cooling to room temperature, the autoclave is opened. There is obtained 118.6 g of clear, brown-colored acetone solution (66 wt %). The structure was confirmed by NMR.
Example 2
Synthesis of 2-(2′-methacroylethoxy)ethyldimethyltetradecylammonium chloride (quat B)
25.0 g of 2-[2-(dimethylamino)ethoxy]ethyl methacrylate, 33.6 ml of 1-chlorotetradecane, 22.8 ml of ethanol, 50 mg of potassium iodide and 12 mg of hydroquinone monomethyl ether are heated for 24 hours with stirring at 105° C. in the autoclave. The pressure rises to about 2 bar. After cooling to room temperature, the autoclave was opened. The quat B is obtained as 75% ethanolic solution. The structure is confirmed by NMR.
Example 3
Preparation of the Copolymer with Quat A
13.3 g of MMA, 10.65 g of butyl acrylate, 4.07 g of quat A solution (66% in acetone, 10 wt % of quat A relative to the mixture of monomers), 0.132 g of 2,2′-azobis-(isobutyronitrile) (AIBN) and 0.1 ml of 2-ethylhexyl thioglycolate are mixed and introduced into a glass chamber (16×16 cm glass plate, 1.5 mm spacer cord) and purged of air bubbles. The chambers are sealed with cement and secured with clamps. Polymerization is carried out for 23 hours at 50° C. in the drying cabinet. After removal of the clamps, the product is heat-treated for 1 hour at 75° C. and 2 hours at 90° C.
Clear, transparent polymers with slightly brownish coloration were obtained (glass transition temperature: 7° C.).
Example 4
Preparation of the Copolymer with Quat B by Emulsion Polvmerization
To 30 g of water there are added 6.89 g of MMA, 5.27 g of butyl acrylate as well as 2.92 g of quat B (as 43% solution) and 0.09 g of 2-ethylhexyl thioglycolate. The mixture is emulsified at 70° C. and a stirring speed of 500 rpm. Then the reaction is initiated at a stirring speed of 250 rpm, using 0.084 g of 2,2′-azobis(2-aminopropane) dihydrochloride (dissolved in 0.1 g of water). After a reaction time of one hour, another 0.042 g of initiator (dissolved in 0.5 g of water) is added to the dispersion, which is then stirred for a further 30 minutes at 70° C. Thereafter the mixture is cooled to room temperature and the dispersion filtered over an ND 70 metal sieve.
Residual monomer content: 296 ppm methyl methacrylate (MMA), 96 ppm butyl acrylate
Solids content: 29.7%
Particle size: 130 nm (no coagulate)
The emulsion was cast on a glass plate bordered with silicone and was dried overnight at 50° C. to obtain a clear, transparent film. Glass transition temperature: 36° C.
Example 5
Preparation of a Comparison Polymer without Functional Monomer b)
Example 3 is repeated, with the difference that a mixture of 22.0 g of MMA, 18.0 g of butyl acrylate, 0.16 g of AIBN and 0.12 g of ethylhexyl thioglycolate is used.
Example 6
Testing of the Polymers from Example 3 and 5 for Bactericidal Properties
The polymer films from Example 3 and 5 were stored for 24 hours in water, during which period the water was replaced after 8 hours. The films were then dried in air. The bactericidal action of these polymer films toward the test organisms Staphylococcus aureus and Bacillus cereus was tested as follows: Each test organism was inoculated with 5 ml of standard I bouillon in an Erlenmeyer flask and incubated as a standard culture for 16 hours at 370° C. The mixture was then diluted by a factor of 1:10000. Strips (5 cm×1 cm) of the polymer films to be examined were coated with 8 ml of this diluted mixture in sterile test tubes. Live germ counts (LGC/g) were then determined immediately and after 2, 4 and 20 hours.
The test tubes were shaken during incubation. The result is summarized in the following table.
Live germ counts (LGC/g)
Staphylococcus aureus
(ATCC 6538) Bacillus cereus (ATCC 2)
Comparison Comparison
Incubation Polymer from polymer Polymer from polymer
time Example 3 (Example 5) Example 3 (Example 5)
none >105 1.2 × 105 >105 6.5 × 103
2 hours 4.2 × 104 3.8 × 104 3.5 × 103 4.5 × 103
4 hours 2.9 × 104 7.1 × 104 1.3 × 103 8.7 × 102
20 hours <101 7.3 × 103 <101 >106
Example 7
Antimicrobial Properties of the Polymers from Examile 3 and 4
a) Contact inhibition of Klebsiella pneumoniae DSM 798 by polymer 4A from Example 3.
The polymer film of polymer 4A from Example 3 was stored in water for 24 hours, the water being replaced after 8 hours. The film was then dried in air.
K. pneumoniae DSM 798 (DSM=German Microorganism Collection) was cultured overnight in YPG whole medium (1% yeast extract, 1% peptone and 1% glucose) at 35° C. The cells were collected by centrifuging and taken up in PBS (0.05 M phosphate buffer solution, pH 7.2, 0.9% NaCl) and the cell count adjusted to 105/ml. 100 μl of the suspension was placed on a patch of the water-treated polymer film of polymer 4A from Example 3. After a contact time of 3 hours in an atmosphere saturated with water vapor, the drop was removed and diluted in 2 ml of saline. The contact area was washed 3 times with saline. 100 μl aliquots were plated on YPG agar. After 18 hours at 37° C., the grown colonies were counted. A patch of polystyrene was used as control polymer. In a parallel experiment, a control test for substances capable of diffusing was performed on YPG agar which had been inoculated with 105 K. pneumoniae germs. No suppression zones were observed. The result is presented in the following table.
Polymer Germ count per plate
Polymer 4A (according to the invention)   0
Polystyrene (control) 3000
b) Selectively inhibiting action of the polymer from Example 4
The contact inhibition test described hereinabove was performed with the polymer from Example 4 (quat B as the comonomer) and four bacterial strains as well as the yeast Candida tropicalis. The films obtained were stored in water for 24 hours (the water being changed several times) and tested after they had been dried in air. The lethality is reported in %. Surprisingly, selective inactivation of the yeast strain was observed, but no action was found for the bacterial strains.
Germ Lethality in %
E. coli K12 ATCC 23716 0
K. pneumoniae DSM 798 0
S. aureus* 0
S. epidermidis ATCC 12228 0
C. tropicalis CBS 6318 70 
* = isolated by Gelsenkirchen Hygiene Institute from an infected central venous catheter
Example 8
Example of use of a Polymer
A polyamide film strip measuring about 8×2 cm was immersed for half of its length into the dispersion from Example 4 and then dried for 1 hour at 70° C. The strip was water-treated for 18 hours and then dried in air at room temperature.
The strip coated for half of its length with the dispersion was now completely immersed in a cell suspension of Staphylococcus aureus (isolated by Gelsenkirchen Hygiene Institute from an infected central venous catheter). Thereafter the strip was dried briefly in air and then placed on dilute nutrient agar and cultured overnight at 370° C.
Result: Compared with 4 Staphylococcus aureus colonies on the half of the polyamide strip coated with the dispersion, several hundred grew on the uncoated half.

Claims (13)

What is claimed is:
1. Polymers with antimicrobial properties, comprising:
a) 99 to 40% by weight of a nonfunctional polymerizable monomer having a terminal ethylenically unsaturated group; and
b) 1 to 60% by weight of a functional polymerizable monomer having a terminal ethylenically unsaturated group of general formula (I)
[V—Ay—HSp]m—N(R1)4−(m+t)—(R2)t.X  (I)
 wherein
V=vinyl, (meth)acroyl, allyl or styryl;
A=a linking unit selected from the group consisting of an alkyl group, an aryl group, an arylalkyl group or a hydroxyalkyl group, a urethane group, a carbonate group, an ester group, an amide group and an ether group;
where y=0 or 1;
Hsp=a hydrophilic spacer of general formula
(i) —(O—CH2—CH2)r— and/or
(ii) —(O—CH2—CH(CH3))s
where r=0 to 40, s=0 to 40 and r+s=2 to 40; and
 wherein
m=1, 2 or 3;
R1=CH3, ethyl or benzyl;
R2=an alkyl residue with 8 to 20 C atoms, where t=1, 2 or 3; and
X=Cl, Br, I or (alkyl sulfate).
2. The polymer according to claim 1, wherein monomer b) is a (meth)acrylic acid ester of general formula (II)
[CH2═CR3—CO—(O—CH2—CHR4)n]m—N(CH3)4−(m+t)—(R2)t.X  (II)
wherein
m=1, 2 or 3, n=2 to 40;
R2=an alkyl residue with 8 to 20 C atoms, where t=1, 2 or 3;
R3=H or CH3;
R4=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
3. The polymer according to claim 1, wherein monomer b) is a (meth)acrylic acid ester of general formula (III)
Figure US06194530-20010227-C00003
wherein
u+v=6 to 20;
R2=an alkyl residue with 8 to 20 C atoms;
R3=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
4. The polymer according to claim 1, wherein monomer b) comprises quat A according to formula (IV)
Figure US06194530-20010227-C00004
wherein u+v=10.
5. The polymer according to claim 1, wherein monomer b) comprises a (meth)acrylic acid ester of general formula (V)
CH2═CR3—CO—(O—CH2—CH2)w—N(CH3)2—R2.X  (V)
wherein
w=2 to 40;
R2=an alkyl residue with 8 to 20 C atoms;
R3=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
6. The polymer according to claim 5, wherein monomer b) comprises quat B of formula (VI)
 CH2═C(CH3)—CO—(O—CH2—CH2)2—N(CH3)2—(C14H29).Cl.  (VI)
7. A plastic or plastic coating, comprising:
the polymer according to claim 1 having an antimicrobial surface.
8. A (meth)acrylate monomer according to formula (II)
[CH2═CR3—CO—(O—CH2—CHR4)n]m—N(CH3)4−(m+t)—(R2)t.X  (II)
wherein
m=1, 2 or 3;
n=2 to 40;
R2=an alkyl residue with 8 to 20 C atoms, where t=1, 2 or 3;
R3=H or CH3;
R4=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
9. The monomer according to claim 8, wherein said monomer has formula (III)
Figure US06194530-20010227-C00005
wherein
u+v=6 to 20;
R2=an alkyl residue with 8 to 20 C atoms;
R3=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
10. The monomer according to claim 8, wherein said monomer has formula (IV)
Figure US06194530-20010227-C00006
wherein u+v=10.
11. The monomer according to claim 8, wherein said monomer has formula (V)
CH2═CR3—CO—(O—CH2—CH2)w—N(CH3)2—R2.X  (V)
wherein
w=2 to 40;
R2=an alkyl residue with 8 to 20 C atoms;
R3=H or CH3; and
X=Cl, Br, I or (alkyl sulfate).
12. The monomer according to claim 11, wherein said monomer has formula (VI)
CH2═C(CH3)—CO—(O—CH2—CH2)2—N(CH3)2—(C14H29).Cl.  (VI)
13. A process for synthesis of an antimicrobial polymer, comprising:
radical polymerizing of 99 to 40% by weight of a nonfinctional polymerizable monomer having a terminal ethylenically unsaturated group and 1 to 60% by weight of a (meth)acrylate monomer according to claim 8.
US09/308,130 1996-11-14 1997-10-21 Polymers with anti-microbial properties Expired - Fee Related US6194530B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19646965 1996-11-14
DE19646965A DE19646965C2 (en) 1996-11-14 1996-11-14 Acrylate-based biophobic polymers, processes for their production and their use
PCT/EP1997/005806 WO1998021253A1 (en) 1996-11-14 1997-10-21 Polymers with anti-microbial properties

Publications (1)

Publication Number Publication Date
US6194530B1 true US6194530B1 (en) 2001-02-27

Family

ID=7811590

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/308,130 Expired - Fee Related US6194530B1 (en) 1996-11-14 1997-10-21 Polymers with anti-microbial properties

Country Status (8)

Country Link
US (1) US6194530B1 (en)
EP (1) EP0938511B1 (en)
JP (1) JP2001504531A (en)
AU (1) AU5051498A (en)
CA (1) CA2271776A1 (en)
DE (2) DE19654897A1 (en)
ES (1) ES2173432T3 (en)
WO (1) WO1998021253A1 (en)

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
US20030175503A1 (en) * 2002-01-16 2003-09-18 3M Innovative Properties Company Pressure sensitive adhesives having quaternary ammonium functionality, articles, and methods
EP1371690A2 (en) * 2002-06-14 2003-12-17 Rohm And Haas Company Polymeric nanoparticle formulations and their use in microbe repellent coatings
EP1371699A2 (en) * 2002-06-14 2003-12-17 Rohm And Haas Company Polymeric nanoparticle and antimicrobial coating formulations
US20030232918A1 (en) * 2002-06-14 2003-12-18 Amick David Richard Aqueous nanaoparticle dispersions
US20040063817A1 (en) * 2002-09-30 2004-04-01 Ilenda Casmir S. Damage resistant coatings, films and articles of manufacture containing crosslinked nanoparticles
US20040063831A1 (en) * 2002-09-30 2004-04-01 Sheppard Aurelia De La Cuesta Polymeric nanoparticle and bioactive coating formulations
US6838078B2 (en) 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20050065284A1 (en) * 1999-08-06 2005-03-24 Venkataram Krishnan Novel latex compositions for deposition on various substrates
WO2005084436A1 (en) * 2004-02-05 2005-09-15 Quick-Med Technologies, Inc. Silicates and other oxides with bonded antimicrobial polymers
US20050246849A1 (en) * 2004-05-10 2005-11-10 Minkler Douglas J Sanitizing handle for cleaning tool
US20050271780A1 (en) * 2000-04-13 2005-12-08 Schroeder Joseph D Method of preserving food using antimicrobial packaging
US20060062850A1 (en) * 2004-09-13 2006-03-23 Chen John C Controlled release antimicrobial polymer compositions
US20060177511A1 (en) * 2002-01-16 2006-08-10 3M Innovative Properties Company Antiseptic compositions and methods
US20060217453A1 (en) * 2002-09-30 2006-09-28 Lauer Rosemarie P Polymeric nanoparticle formulations and their use for improving the dirt pick up resistance of a coating
US20060269493A1 (en) * 2004-02-05 2006-11-30 Quick-Med Technologies, Inc. Silicate and other oxide powders with bonded anitmicrobial polymers
US20070122438A1 (en) * 2004-10-28 2007-05-31 Wynne James H Multifunctional self-decontaminating surface coating
US20070134811A1 (en) * 2005-12-13 2007-06-14 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
US20070149694A1 (en) * 2003-07-03 2007-06-28 Venkataram Krishnan Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US20070254979A1 (en) * 2006-04-28 2007-11-01 Ivoclar Vivadent Ag Dental materials based on radically polymerizable macromers with antimicrobial effect
US20080057049A1 (en) * 2006-08-24 2008-03-06 Venkataram Krishnan Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US20080207774A1 (en) * 2006-08-24 2008-08-28 Venkataram Krishnan Anionic latex as a carrier for active ingredients and methods for making and using the same
US20080226584A1 (en) * 2003-07-03 2008-09-18 Venkataram Krishnan Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
US20080233062A1 (en) * 2006-08-24 2008-09-25 Venkataram Krishnan Cationic latex as a carrier for active ingredients and methods for making and using the same
US7459167B1 (en) * 2000-07-27 2008-12-02 3M Innovative Properties Company Biocidal polyurethane compositions and methods of use
DE102007031473A1 (en) 2007-07-05 2009-01-08 Evonik Röhm Gmbh Process for the preparation of ethylene glycol dimethacrylate
DE102007031470A1 (en) 2007-07-05 2009-01-08 Evonik Röhm Gmbh Process for the preparation of (meth) acrylates
US20090117164A1 (en) * 2005-08-22 2009-05-07 Quick-Med Technologies, Inc. Disinfectant with Durable Activity Based on Alcohol-Soluble Quaternary Ammonium Polymers and Copolymers
WO2009148880A2 (en) * 2008-05-29 2009-12-10 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
US20100003212A1 (en) * 2006-06-26 2010-01-07 Kis Georg L Polymers with antimicrobial activity containing quaternary ammonium groups
DE102008040221A1 (en) 2008-07-07 2010-01-14 Evonik Röhm Gmbh Process for the preparation of (meth) acrylic esters
US20100136143A1 (en) * 2007-04-03 2010-06-03 Shmuel Bukshpan New compositions and methods for cell killing
US20100178427A1 (en) * 2007-04-25 2010-07-15 Ciba Corporation Substrates with biocidal coating
EP2231761A2 (en) * 2008-01-08 2010-09-29 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
WO2011038897A3 (en) * 2009-09-29 2011-11-24 Lonza Inc Method for imparting antibiotic activity to the surface of a solid substrate
DE102011081649A1 (en) 2011-08-26 2013-02-28 Evonik Röhm Gmbh Longer chain methacrylates from renewable raw materials
US8785519B2 (en) 2006-08-24 2014-07-22 Mallard Creek Polymers, Inc. Anionic latex as a carrier for bioactive ingredients and methods for making and using the same
CN104968198A (en) * 2013-02-01 2015-10-07 禾大国际股份公开有限公司 Self-disinfecting surfaces
US20170007464A1 (en) * 2013-12-20 2017-01-12 3M Innovative Properties Company Antimicrobial pressure-sensitive adhesive system
US9920062B2 (en) 2013-04-09 2018-03-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antimicrobial monomers and polymers, and their use in dental devices
EP3395454A1 (en) * 2017-04-26 2018-10-31 Fast&Fluid Management B.V. Dispenser for tinting pastes
US11134684B2 (en) 2005-08-24 2021-10-05 Purdue Research Foundation Method of using hydrophilized bactericidal polymers
US11421084B2 (en) 2017-05-27 2022-08-23 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
US11680116B2 (en) 2017-06-16 2023-06-20 Poly Group LLC Polymeric antimicrobial surfactant

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161108A1 (en) 2000-03-09 2002-10-31 Stepan Company, A Corporation Of The State Of Delaware Emulsion polymerization process utilizing ethylenically unsaturated amine salts of sulfonic, phosphoric and carboxylic acids
US7423167B2 (en) 1997-01-28 2008-09-09 Stepan Company Ethylenically unsaturated amine salts of sulfonic, phosphoric and carboxylic acids
US6242526B1 (en) 1997-01-28 2001-06-05 Stepan Company Antimicrobial polymer latexes derived from unsaturated quaternary ammonium compounds and antimicrobial coatings, sealants, adhesives and elastomers produced from such latexes
JP2001509195A (en) 1997-01-28 2001-07-10 ステパン カンパニー Improved emulsion polymerization process using ethylenically unsaturated amine salts of sulfonic, phosphoric and carboxylic acids
GB2363715A (en) * 2000-06-21 2002-01-09 Peter Goodwin Germ and fungal resistant fabrics
DE10127513A1 (en) * 2001-06-06 2002-12-12 Creavis Tech & Innovation Gmbh Antimicrobial non-woven fabric containing antimicrobial polymer, used e.g. in filters
WO2004106023A1 (en) * 2002-04-21 2004-12-09 Quick-Med Technologies, Inc. Materials and methods for treating lumber and wood products
DE10302174A1 (en) * 2003-01-22 2004-08-05 Clariant Gmbh New copolymers used for biocidal finishing of textile or surface, e.g. in cleaner for stainless steel or PVC tiles, are derived from new or known acrylate and acrylamide monomers with quaternized ammonium or amino group
WO2004076770A1 (en) 2003-02-25 2004-09-10 Quick-Med Technologies, Inc. Improved antifungal gypsum board
CA2926945A1 (en) 2013-06-25 2014-12-31 Ricardo Benavides Perez Bacteriostatic and fungistatic additive in masterbatch for application in plastics, and method for producing same
AR097482A1 (en) * 2013-08-28 2016-03-16 Basf Se ANTIMICROBIAL CONFORMATION COATINGS
JP2016017130A (en) * 2014-07-08 2016-02-01 互応化学工業株式会社 Bacterium adhesion-suppressed resin
JP6535192B2 (en) * 2015-03-25 2019-06-26 株式会社日本触媒 Antimicrobial agent
WO2018232025A1 (en) * 2017-06-16 2018-12-20 Yichieh Shiuey Cell growth inhibiting copolymer for use in ophthalmic implants
TR201908578A2 (en) * 2019-06-10 2020-12-21 Univ Sabanci Microbial growth resistant paint formulation and method for its preparation.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824867A (en) * 1986-08-08 1989-04-25 Smith Kim R Quaternary ammonium compounds
WO1991012282A1 (en) * 1990-02-14 1991-08-22 H.B. Fuller Licensing & Financing Inc. Copolymers with inherent antimicrobial action
EP0525751A1 (en) * 1991-07-30 1993-02-03 Hymo Corporation Process for the preparation of dispersion of water-soluble cationic polymer
US5300287A (en) * 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
US5408022A (en) * 1991-10-18 1995-04-18 Kuraray Co., Ltd. Antimicrobial polymerizable composition, the polymer and article obtained from the same
US5476913A (en) * 1992-07-06 1995-12-19 Otsuka Kagaku Kabushiki Kaisha Polymerizable monomer, polymer thereof and process for preparing same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318170D0 (en) * 1993-09-02 1993-10-20 Kodak Ltd Antimicrobial polymers and compositions containing them

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824867A (en) * 1986-08-08 1989-04-25 Smith Kim R Quaternary ammonium compounds
WO1991012282A1 (en) * 1990-02-14 1991-08-22 H.B. Fuller Licensing & Financing Inc. Copolymers with inherent antimicrobial action
EP0525751A1 (en) * 1991-07-30 1993-02-03 Hymo Corporation Process for the preparation of dispersion of water-soluble cationic polymer
US5408022A (en) * 1991-10-18 1995-04-18 Kuraray Co., Ltd. Antimicrobial polymerizable composition, the polymer and article obtained from the same
US5476913A (en) * 1992-07-06 1995-12-19 Otsuka Kagaku Kabushiki Kaisha Polymerizable monomer, polymer thereof and process for preparing same
US5300287A (en) * 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions

Cited By (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
US7709694B2 (en) 1998-12-08 2010-05-04 Quick-Med Technologies, Inc. Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20050065284A1 (en) * 1999-08-06 2005-03-24 Venkataram Krishnan Novel latex compositions for deposition on various substrates
US20050271780A1 (en) * 2000-04-13 2005-12-08 Schroeder Joseph D Method of preserving food using antimicrobial packaging
US7981408B2 (en) * 2000-04-13 2011-07-19 Boston Brands, Inc. Method of preserving food using antimicrobial packaging
US7459167B1 (en) * 2000-07-27 2008-12-02 3M Innovative Properties Company Biocidal polyurethane compositions and methods of use
EP1450966A2 (en) * 2001-09-28 2004-09-01 Quick Med Technologies, Inc. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
EP1450966A4 (en) * 2001-09-28 2009-09-09 Quick Med Technologies Inc Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US7005031B2 (en) 2002-01-16 2006-02-28 3M Innovative Properties Company Pressure sensitive adhesives having quaternary ammonium functionality, articles, and methods
US8840932B2 (en) 2002-01-16 2014-09-23 3M Innovative Properties Company Antiseptic compositions and methods
US20050025794A1 (en) * 2002-01-16 2005-02-03 3M Innovative Properties Company Film-forming compositions and methods
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US6838078B2 (en) 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US7323163B2 (en) 2002-01-16 2008-01-29 3M Innovative Properties Company Film-forming compositions and methods
US20030175503A1 (en) * 2002-01-16 2003-09-18 3M Innovative Properties Company Pressure sensitive adhesives having quaternary ammonium functionality, articles, and methods
US9277750B2 (en) 2002-01-16 2016-03-08 3M Innovative Properties Company Antiseptic compositions and methods
US20060177511A1 (en) * 2002-01-16 2006-08-10 3M Innovative Properties Company Antiseptic compositions and methods
EP1371699A3 (en) * 2002-06-14 2004-01-14 Rohm And Haas Company Polymeric nanoparticle and antimicrobial coating formulations
US7244784B2 (en) 2002-06-14 2007-07-17 Rohm And Haas Company Aqueous nanoparticle dispersions
EP1371690A2 (en) * 2002-06-14 2003-12-17 Rohm And Haas Company Polymeric nanoparticle formulations and their use in microbe repellent coatings
EP1371699A2 (en) * 2002-06-14 2003-12-17 Rohm And Haas Company Polymeric nanoparticle and antimicrobial coating formulations
US20030232918A1 (en) * 2002-06-14 2003-12-18 Amick David Richard Aqueous nanaoparticle dispersions
EP1371690A3 (en) * 2002-06-14 2004-04-28 Rohm And Haas Company Polymeric nanoparticle formulations and their use in microbe repellent coatings
US7138438B2 (en) 2002-09-30 2006-11-21 Rohm And Haas Company Polymeric nanoparticle formulations and their use for improving the dirt pick up resistance of a coating
US20060217453A1 (en) * 2002-09-30 2006-09-28 Lauer Rosemarie P Polymeric nanoparticle formulations and their use for improving the dirt pick up resistance of a coating
US7244775B2 (en) 2002-09-30 2007-07-17 Rohm And Haas Company Damage resistant coatings, films and articles of manufacture containing crosslinked nanoparticles
US20040063817A1 (en) * 2002-09-30 2004-04-01 Ilenda Casmir S. Damage resistant coatings, films and articles of manufacture containing crosslinked nanoparticles
US20040063831A1 (en) * 2002-09-30 2004-04-01 Sheppard Aurelia De La Cuesta Polymeric nanoparticle and bioactive coating formulations
US20070149694A1 (en) * 2003-07-03 2007-06-28 Venkataram Krishnan Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US7781498B2 (en) 2003-07-03 2010-08-24 Mallard Creek Polymers, Inc. Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US7981946B2 (en) 2003-07-03 2011-07-19 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
US20080226584A1 (en) * 2003-07-03 2008-09-18 Venkataram Krishnan Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
US20060269493A1 (en) * 2004-02-05 2006-11-30 Quick-Med Technologies, Inc. Silicate and other oxide powders with bonded anitmicrobial polymers
WO2005084436A1 (en) * 2004-02-05 2005-09-15 Quick-Med Technologies, Inc. Silicates and other oxides with bonded antimicrobial polymers
US20050246849A1 (en) * 2004-05-10 2005-11-10 Minkler Douglas J Sanitizing handle for cleaning tool
US20060062850A1 (en) * 2004-09-13 2006-03-23 Chen John C Controlled release antimicrobial polymer compositions
US20080102281A1 (en) * 2004-10-28 2008-05-01 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Multifunctional self-decontaminating surface coating
US7452951B2 (en) * 2004-10-28 2008-11-18 The United States Of America As Represented By The Secretary Of The Navy Multifunctional self-decontaminating surface coating
US7339015B2 (en) * 2004-10-28 2008-03-04 The United States Of America As Represented By The Secretary Of The Navy Multifunctional self-decontaminating surface coating
US20070122438A1 (en) * 2004-10-28 2007-05-31 Wynne James H Multifunctional self-decontaminating surface coating
US8343523B2 (en) * 2005-08-22 2013-01-01 Quick-Med Technologies, Inc. Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers
US20090117164A1 (en) * 2005-08-22 2009-05-07 Quick-Med Technologies, Inc. Disinfectant with Durable Activity Based on Alcohol-Soluble Quaternary Ammonium Polymers and Copolymers
US11134684B2 (en) 2005-08-24 2021-10-05 Purdue Research Foundation Method of using hydrophilized bactericidal polymers
US11459415B2 (en) 2005-08-24 2022-10-04 Purdue Research Foundation Method of using hydrophilized bactericidal polymers
US20070134811A1 (en) * 2005-12-13 2007-06-14 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
US7553881B2 (en) * 2006-04-28 2009-06-30 Ivoclar Vivadent Ag Dental materials based on radically polymerizable macromers with antimicrobial effect
US20070254979A1 (en) * 2006-04-28 2007-11-01 Ivoclar Vivadent Ag Dental materials based on radically polymerizable macromers with antimicrobial effect
AU2007264041B2 (en) * 2006-06-26 2011-07-07 Novartis Ag Polymers with antimicrobial activity containing quaternary ammonium groups
US20100003212A1 (en) * 2006-06-26 2010-01-07 Kis Georg L Polymers with antimicrobial activity containing quaternary ammonium groups
CN101478976B (en) * 2006-06-26 2013-11-13 诺瓦提斯公司 Polymers with antimicrobial activity containing quaternary ammonium groups
US9220725B2 (en) 2006-08-24 2015-12-29 Mallard Creek Polymers, Inc. Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US20080057049A1 (en) * 2006-08-24 2008-03-06 Venkataram Krishnan Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US20080207774A1 (en) * 2006-08-24 2008-08-28 Venkataram Krishnan Anionic latex as a carrier for active ingredients and methods for making and using the same
US20080233062A1 (en) * 2006-08-24 2008-09-25 Venkataram Krishnan Cationic latex as a carrier for active ingredients and methods for making and using the same
US8785519B2 (en) 2006-08-24 2014-07-22 Mallard Creek Polymers, Inc. Anionic latex as a carrier for bioactive ingredients and methods for making and using the same
US20100136143A1 (en) * 2007-04-03 2010-06-03 Shmuel Bukshpan New compositions and methods for cell killing
US20100178427A1 (en) * 2007-04-25 2010-07-15 Ciba Corporation Substrates with biocidal coating
US8591994B2 (en) 2007-04-25 2013-11-26 Ciba Corporation Substrates with biocidal coating
DE102007031470A1 (en) 2007-07-05 2009-01-08 Evonik Röhm Gmbh Process for the preparation of (meth) acrylates
DE102007031473A1 (en) 2007-07-05 2009-01-08 Evonik Röhm Gmbh Process for the preparation of ethylene glycol dimethacrylate
EP2231761A2 (en) * 2008-01-08 2010-09-29 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
EP2231761A4 (en) * 2008-01-08 2013-08-14 Quick Med Technologies Inc Disinfectant alcohol-soluble quaternary ammonium polymers
WO2009137016A2 (en) 2008-05-06 2009-11-12 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
WO2009148880A3 (en) * 2008-05-29 2010-08-05 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
AU2009255322B2 (en) * 2008-05-29 2015-12-03 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
WO2009148880A2 (en) * 2008-05-29 2009-12-10 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
US20110124772A1 (en) * 2008-05-29 2011-05-26 Dsm Ip Assets B.V. Antimicrobial polymers and their uses
DE102008040221A1 (en) 2008-07-07 2010-01-14 Evonik Röhm Gmbh Process for the preparation of (meth) acrylic esters
CN102573465A (en) * 2009-09-29 2012-07-11 隆萨公司 Method for imparting antibiotic activity to the surface of a solid substrate
WO2011038897A3 (en) * 2009-09-29 2011-11-24 Lonza Inc Method for imparting antibiotic activity to the surface of a solid substrate
DE102011081649A1 (en) 2011-08-26 2013-02-28 Evonik Röhm Gmbh Longer chain methacrylates from renewable raw materials
US9803090B2 (en) * 2013-02-01 2017-10-31 Croda International Plc Self-disinfecting surfaces
US10266705B2 (en) * 2013-02-01 2019-04-23 Croda International Plc Self-disinfecting surfaces
CN104968198A (en) * 2013-02-01 2015-10-07 禾大国际股份公开有限公司 Self-disinfecting surfaces
CN104968198B (en) * 2013-02-01 2018-02-13 禾大国际股份公开有限公司 From disinfecting surface
AU2014211319B2 (en) * 2013-02-01 2017-05-18 Croda International Plc Self-disinfecting surfaces
US20150361276A1 (en) * 2013-02-01 2015-12-17 Croda International Plc Self-disintecting surfaces
US9920062B2 (en) 2013-04-09 2018-03-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antimicrobial monomers and polymers, and their use in dental devices
US10392394B2 (en) 2013-04-09 2019-08-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antimicrobial compounds and methods
US20170007464A1 (en) * 2013-12-20 2017-01-12 3M Innovative Properties Company Antimicrobial pressure-sensitive adhesive system
EP3395454A1 (en) * 2017-04-26 2018-10-31 Fast&Fluid Management B.V. Dispenser for tinting pastes
EP4147799A3 (en) * 2017-04-26 2023-05-17 Fast & Fluid Management B.V. Dispenser for tinting pastes
US11421084B2 (en) 2017-05-27 2022-08-23 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
US11760844B2 (en) 2017-05-27 2023-09-19 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
US11680116B2 (en) 2017-06-16 2023-06-20 Poly Group LLC Polymeric antimicrobial surfactant

Also Published As

Publication number Publication date
ES2173432T3 (en) 2002-10-16
EP0938511A1 (en) 1999-09-01
DE19654897A1 (en) 1998-06-04
DE59706518D1 (en) 2002-04-04
JP2001504531A (en) 2001-04-03
WO1998021253A1 (en) 1998-05-22
EP0938511B1 (en) 2002-02-27
AU5051498A (en) 1998-06-03
CA2271776A1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
US6194530B1 (en) Polymers with anti-microbial properties
US6242526B1 (en) Antimicrobial polymer latexes derived from unsaturated quaternary ammonium compounds and antimicrobial coatings, sealants, adhesives and elastomers produced from such latexes
AU609461B2 (en) Aqueous biocidal cationic dispersions of polymers and their use as fungicidal, bactericidal and algicidal treatment agents
US9220725B2 (en) Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
JP2609269B2 (en) Improved disinfectant polymer coating for hard surfaces
US4999386A (en) Disinfectant polymeric coatings from esters of α,β-unsaturated carboxylic acid and germicide
US6469177B1 (en) Surface active N-Halamine compounds
DE19646965C2 (en) Acrylate-based biophobic polymers, processes for their production and their use
EP1268580A1 (en) Microbicidal coatings containing acrylo-substituted alkylsulphonic acid polymers
DE19921895A1 (en) Antimicrobial copolymer for medical and hygiene articles, varnishes, paints and coatings comprises monomers with an ester group(s) and a tert. amino group(s) and monomers having an amino group(s)
CA1302239C (en) Disinfectant polymeric coatings for hard surfaces
EP1214366A1 (en) Copolymers of aminopropyl vinyl ether
EP1183292A1 (en) Microbicidal copolymers
EP1183293A1 (en) Microbicidal copolymers
EP1183288A1 (en) Microbicidal copolymers
JP3644813B2 (en) Method for producing acrylic emulsion
JP3711412B2 (en) Antibacterial agent, antibacterial fiber and method for producing the same
WO2023234926A1 (en) Pest control compositions
Gerrard et al. Kammartige Kopolymere helfen, die antibakterielle Wirkung von stark wasserlöslichen kationischen Bioziden an der Oberfläche zu erhalten

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROEHM GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KLESSE, WOLFGANG;PFIRMANN, MARTINA;HILL, HELLA AS HEIRESS FOR FRANK HILL (DECEASED);REEL/FRAME:011328/0069;SIGNING DATES FROM 19990628 TO 19990707

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: EVONIK ROHM GMBH,GERMANY

Free format text: CHANGE OF NAME;ASSIGNOR:ROHM GMBH;REEL/FRAME:023998/0594

Effective date: 20070925

Owner name: EVONIK ROHM GMBH, GERMANY

Free format text: CHANGE OF NAME;ASSIGNOR:ROHM GMBH;REEL/FRAME:023998/0594

Effective date: 20070925

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20130227